Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/08/2000 | CN1272846A 8-substituted-9H-1,3-dioxolo/4,5-h/2,3/benzodiazepine derivatives, as Ampa/kainate receptor inhibitors |
11/08/2000 | CN1272845A Process for preparation of oxymorphone, oxycodone and derivatives |
11/08/2000 | CN1272841A Novel lactam metalloprotease inhibitors |
11/08/2000 | CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments |
11/08/2000 | CN1272788A Method for treating psychosis associated with glucocorticoid related dysfunction |
11/08/2000 | CN1272784A Medicinal compositions for application to mucosa |
11/08/2000 | CN1272493A Novel amino-triazole compound, its preparation method and drug composition containing them |
11/08/2000 | CN1272372A Drink for dispelling effects of liquor and its preparation method |
11/08/2000 | CN1272369A Medicine for giving up drugs |
11/08/2000 | CN1272363A Preparation method of medicine for resisting ischemic cerebrum and brain trauma using taurine |
11/08/2000 | CN1272337A Kelp product (II) and its production method and application |
11/08/2000 | CN1272336A Kelp product and its production method and application |
11/08/2000 | CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands |
11/08/2000 | CN1058158C Drug composition for curing heart and brain vascular diseases |
11/08/2000 | CN1058152C Henbane drug give-up agent and its preparation and use |
11/07/2000 | US6143792 Treatment of sleep apnea syndrome |
11/07/2000 | US6143789 Enantiomorphs |
11/07/2000 | US6143783 Amino acids |
11/07/2000 | US6143772 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof |
11/07/2000 | US6143762 Tetrahydroisoquinoline derivatives and their pharmaceutical use |
11/07/2000 | US6143761 2,3-dihydrofuro [3,2-β]pyridin, preparation and application thereof in therapy |
11/07/2000 | US6143749 Heterocyclic substituted cyclopentane compounds |
11/07/2000 | US6143743 Treatment of nervous system disorders |
11/07/2000 | US6143733 Drugs for central nervous system diseases such as parkinson's disease, alzheimer's disease, huntington chorea, amyotrophic lateral sclerosis and olivopontocerebellar degeneration, psychiatric diseases such as anxiety conditions, migraine |
11/07/2000 | US6143722 To controll uterine contractions in treating preterm labor |
11/07/2000 | US6143521 Human bombesin receptor subtype-3sb |
11/07/2000 | US6143325 Ph modulation; sustained release |
11/07/2000 | US6143322 Method of treating humans with opioid formulations having extended controlled release |
11/07/2000 | US6143302 Headache and colic relief composition with asafetida and method of use thereof |
11/07/2000 | CA2179306C Dopamine receptor ligands |
11/07/2000 | CA2170485C Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
11/07/2000 | CA2166981C Oncoprotein protein kinase |
11/07/2000 | CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them |
11/07/2000 | CA2083913C Piperazinyl-and piperidinyl-cyclohexanols |
11/07/2000 | CA2022488C 2,3-dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments |
11/07/2000 | CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties |
11/02/2000 | WO2000065054A2 Human membrane-associated proteins |
11/02/2000 | WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
11/02/2000 | WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
11/02/2000 | WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
11/02/2000 | WO2000064911A1 Ligands for metabotropic glutamate receptors |
11/02/2000 | WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
11/02/2000 | WO2000064898A1 Azaindole derivatives for the treatment of depression |
11/02/2000 | WO2000064897A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament |
11/02/2000 | WO2000064886A1 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression |
11/02/2000 | WO2000064885A1 Heteroaryl diazacycloalkanes, their preparation and use |
11/02/2000 | WO2000064880A1 Selective npy (y5) antagonists |
11/02/2000 | WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
11/02/2000 | WO2000064877A1 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
11/02/2000 | WO2000064859A1 Amide derivatives |
11/02/2000 | WO2000064538A1 Products and methods for brachytherapy |
11/02/2000 | WO2000064486A2 Enzymatically activated polymeric drug conjugates |
11/02/2000 | WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof |
11/02/2000 | WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
11/02/2000 | WO2000064473A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
11/02/2000 | WO2000064462A1 Pharmaceutical compositions containing selegiline and ginkgo biloba extract useful for dementia |
11/02/2000 | WO2000064460A2 Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin |
11/02/2000 | WO2000064459A1 Cell therapy for chronic stroke |
11/02/2000 | WO2000064441A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
11/02/2000 | WO2000064436A1 Methods of delivery of cetyl myristoleate |
11/02/2000 | WO2000064426A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
11/02/2000 | WO2000064423A2 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders |
11/02/2000 | WO2000064422A2 Novel treatment of neurotraumatic conditions with raf inhibitor |
11/02/2000 | WO2000064421A2 Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients |
11/02/2000 | WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives |
11/02/2000 | WO2000064415A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
11/02/2000 | WO2000042042A3 High affinity inhibitors for target validation and uses thereof |
11/02/2000 | WO2000040714A3 Therapeutic phosphodiesterase inhibitors |
11/02/2000 | WO2000040699A3 Astrocytes, their preparation and uses thereof |
11/02/2000 | WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
11/02/2000 | WO2000039299A3 Streptococcus antigens |
11/02/2000 | WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
11/02/2000 | WO2000039136A3 Human brainiac-5 |
11/02/2000 | WO2000037642A9 Method of enhancing the biological activity of ligands |
11/02/2000 | WO2000018917A3 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
11/02/2000 | WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL |
11/02/2000 | EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses |
11/02/2000 | EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species |
11/02/2000 | EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein |
11/02/2000 | EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |
11/02/2000 | EP1047713A1 Secreted proteins and polynucleotides encoding them |
11/02/2000 | EP1047711A1 Nucleic acid sequences encoding capsaicin receptors |
11/02/2000 | EP1047698A1 Piperazino derivatives as neurokinin antagonists |
11/02/2000 | EP1047697A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
11/02/2000 | EP1047691A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists |
11/02/2000 | EP1047690A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
11/02/2000 | EP1047688A1 Thiophene nitrone compounds |
11/02/2000 | EP1047686A1 Substituted bicyclic lactones |
11/02/2000 | EP1047685A1 Substituted beta,gamma-anellated lactones |
11/02/2000 | EP1047684A1 Substituted alpha,beta-anellated butyrolactones |
11/02/2000 | EP1047683A1 Thioether furan nitrone compounds |
11/02/2000 | EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
11/02/2000 | EP1047675A1 Chemokine receptor antagonists and methods of use therefor |
11/02/2000 | EP1047673A1 Novel heterocyclic compounds |
11/02/2000 | EP1047670A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels |
11/02/2000 | EP1047664A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
11/02/2000 | EP1047663A1 A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL- 2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE |
11/02/2000 | EP1047449A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
11/02/2000 | EP1047444A1 Methods of neuroendocrine regulation of affective disorders |
11/02/2000 | EP1047440A1 St. john's wort and methyl donor composition and uses thereof |